Analyst Ratings for NovaBay Pharmaceuticals (nby)

nby Rating Summary

  |   Expand Research on nby
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/6/2013 Ascendiant Capital New Coverage Strong Buy
(N/A)
2.25
(N/A)
1.15 1.00 -13.04% Details
4/12/2012 Roth Capital New Coverage Buy
(N/A)
3.50
(N/A)
1.28 1.00 -21.88% Details